Effects of GH on lipid peroxidation and neutrophil superoxide anion‐generating capacity in hypopituitary adults with GH deficiency

objectives  Untreated growth hormone deficiency (GHD) is implicated in the increased cardiovascular risk associated with adult hypopituitarism. Oxidative stress, predisposing to lipid peroxidation, may be an important mediator of endothelial dysfunction, a pro‐atherogenic state associated with adult GHD.

[1]  C. Wiedermann,et al.  Superoxide anion release from neutrophils in growth hormone deficient adults before and after replacement therapy with recombinant human growth hormone , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  K. Wheatley,et al.  Association between premature mortality and hypopituitarism , 2001, The Lancet.

[3]  S. Jackson,et al.  Neutrophil superoxide anion--generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy. , 2000, Journal of the American College of Cardiology.

[4]  B. Babior.  Phagocytes and oxidative stress. , 2000, The American journal of medicine.

[5]  N. Rifai,et al.  Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency , 2000, Annals of Internal Medicine.

[6]  J. Kvasnička,et al.  Increase of adhesion molecules, fibrinogen, type‐1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement , 2000, Clinical endocrinology.

[7]  A M Zeiher,et al.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.

[8]  A. Bartke,et al.  Effects of growth hormone on hypothalamic catalase and Cu/Zn superoxide dismutase1 , 2000 .

[9]  S. Jackson,et al.  The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. , 2000, European journal of endocrinology.

[10]  A. Bartke,et al.  Effects of growth hormone on hypothalamic catalase and Cu/Zn superoxide dismutase. , 2000, Free radical biology & medicine.

[11]  J. Goodfellow,et al.  Endothelial dysfunction in hypopituitary adults with growth hormone deficiency , 1999, Clinical endocrinology.

[12]  R. Clayton,et al.  Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. , 1999, The Journal of clinical endocrinology and metabolism.

[13]  D. Johnston,et al.  Cardiovascular disease and risk factors in adults with hypopituitarism , 1999, Clinical endocrinology.

[14]  O. Serri,et al.  Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy. , 1999, The Journal of clinical endocrinology and metabolism.

[15]  L. Berglund,et al.  Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[16]  M. Rubenfire,et al.  Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease. , 1997, The American journal of cardiology.

[17]  J. Keaney,et al.  Antioxidants and atherosclerotic heart disease. , 1997, The New England journal of medicine.

[18]  R. Clark,et al.  The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function. , 1997, Endocrine reviews.

[19]  L. Hagmar,et al.  Increased cerebrovascular mortality in patients with hypopituitarism , 1997, Clinical endocrinology.

[20]  G. Brabant,et al.  Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. , 1996, The Journal of clinical investigation.

[21]  D. O'Neal,et al.  Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy. , 1996, The Journal of clinical endocrinology and metabolism.

[22]  A. Yeung,et al.  Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. , 1996, Circulation.

[23]  A. Vaag,et al.  Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. , 1996, The Journal of clinical endocrinology and metabolism.

[24]  J. Nourooz-Zadeh,et al.  Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations. , 1996, The Biochemical journal.

[25]  D. Betteridge,et al.  Elevated Levels of Authentic Plasma Hydroperoxides in NIDDM , 1995, Diabetes.

[26]  E. Hooghe-Peters,et al.  Growth Hormone, Prolactin and IGF-I as Lymphohemopoietic Cytokines , 1995 .

[27]  I. Mcdowell,et al.  A Rapid Method for Measurement of the Susceptibility to Oxidation of Low-Density Lipoprotein , 1995, Annals of clinical biochemistry.

[28]  L. Tenkanen,et al.  Antibody against oxidized low-density lipoprotein predicting myocardial infarction. , 1994, Archives of internal medicine.

[29]  M. Kendall,et al.  The oxidation hypothesis of atherosclerosis , 1994, The Lancet.

[30]  J. Nourooz-Zadeh,et al.  Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. , 1994, Analytical biochemistry.

[31]  E. Anggard,et al.  Oxidative modification of low-density lipoprotein by human polymorphonuclear leucocytes to a form recognised by the lipoprotein scavenger pathway. , 1994, Biochimica et biophysica acta.

[32]  K. Kugiyama,et al.  Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C. , 1994, Circulation research.

[33]  R. Manfredi,et al.  Growth Hormone (GH) and the Immune System: Impaired Phagocytic Function in Children with Idiopathic GH Deficiency is Corrected by Treatment with Biosynthetic GH , 1994, The Journal of pediatric endocrinology.

[34]  I. Jialal,et al.  LDL modification by activated polymorphonuclear leukocytes: a cellular model of mild oxidative stress. , 1994, Free radical biology & medicine.

[35]  C. Wiedermann,et al.  Stimulation of monocyte chemotaxis by human growth hormone and its deactivation by somatostatin. , 1993, Blood.

[36]  R. Krauss,et al.  Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. , 1992, Atherosclerosis.

[37]  R. Dantzer,et al.  Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. , 1992, The Journal of clinical investigation.

[38]  B. Hoffman,et al.  Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. , 1992, The Journal of clinical investigation.

[39]  M. Gidlund,et al.  Biologically modified LDL increases the adhesive properties of endothelial cells. , 1991, Atherosclerosis.

[40]  G. Specchia,et al.  Granulocyte function in coronary artery disease. , 1991, The American journal of cardiology.

[41]  B. Bengtsson,et al.  Premature mortality due to cardiovascular disease in hypopituitarism , 1990, The Lancet.

[42]  B. Healy.  Endothelial cell dysfunction: an emerging endocrinopathy linked to coronary disease. , 1990, Journal of the American College of Cardiology.

[43]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[44]  U. Steinbrecher.  Role of superoxide in endothelial-cell modification of low-density lipoproteins. , 1988, Biochimica et biophysica acta.

[45]  K. Kelley,et al.  A newly defined property of somatotropin: priming of macrophages for production of superoxide anion. , 1988, Science.

[46]  H. Gyllenhammar,et al.  Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. , 1987, Journal of immunological methods.

[47]  W. Kiess,et al.  Specific growth hormone receptors on human peripheral mononuclear cells: reexpression, identification, and characterization. , 1985, The Journal of clinical endocrinology and metabolism.

[48]  P. Henson,et al.  Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro. , 1984, The Journal of clinical investigation.

[49]  B. Babior,et al.  Oxygen-dependent microbial killing by phagocytes (second of two parts). , 1978, The New England journal of medicine.